MENU
AGIO
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Agios Pharmaceuticals (AGIO) Ownership - Who owns Agios Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
88 Sidney Street
Phone
+1 617 649-8600
Employees
386
Web
https://www.agios.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.59B
P/E Ratio
N/A
Total Cash
569.89M
Projected Growth
N/A
Total Debt
64.62M
Revenue
31.31M
Risk (Beta)
0.47
Dividend Yield
N/A
Total Cash/Share
10.02
Total Debt/Equity
N/A
Revenue/Share
0.56 USD as % of share price
Fundamentals
AGIO
Capitalization
2.6B
P/E Ratio
N/A
Risk (Beta)
0.47
Dividend Yield
N/A
Total Cash
570M
Total Cash/Share
10.02
Total Debt
64.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.56%
Revenue
31.3M
ROE
N/A
Book Value
661M
P/B Ratio
3.83
Cash Flow
N/A
Earnings
-6.5
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
73K
Current Ratio
10.09
Current Revenue Per Employee
22318.65
Dividends Per Share - Security
N/A
EBITDA
-399.1M
Float
N/A
Float - Current
N/A
Gross Income Margin
82.65
Revenue To Assets
-39.28
Shares Held By Institutions
4.79B
Shares Outstanding - Current
56.9M
Total Liabilities
113M
Total Volume MTD
N/A
Value
N/A
Gain YTD
96.228
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutics
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
88 Sidney Street
Phone
+1 617 649-8600
Employees
386
Web
https://www.agios.com